Loading…
Universe Pharmaceuticals INC is projected to decline to $2.36 by 2027, a -17% move from its current price of $2.85. UPC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.72 | $2.85 | $2.99 | -0.05% |
| May 30 | $2.66 | $2.85 | $3.04 | -0.10% |
| May 31 | $2.62 | $2.85 | $3.09 | -0.15% |
| Jun 1 | $2.59 | $2.84 | $3.12 | -0.20% |
| Jun 2 | $2.56 | $2.84 | $3.16 | -0.25% |
| Jun 3 | $2.53 | $2.84 | $3.19 | -0.30% |
| Jun 4 | $2.51 | $2.84 | $3.22 | -0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.51 | $2.84 | $3.22 | -0.35% |
| Week 2 | $2.37 | $2.83 | $3.37 | -0.70% |
| Week 3 | $2.27 | $2.82 | $3.50 | -1.05% |
| Week 4 | $2.19 | $2.81 | $3.60 | -1.40% |
| Week 5 | $2.12 | $2.80 | $3.70 | -1.75% |
| Week 6 | $2.06 | $2.79 | $3.78 | -2.09% |
| Week 7 | $2.00 | $2.78 | $3.86 | -2.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company serves pharmaceutical companies, hospitals, clinics, and drugstore chains.
The portfolio targets the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity, and cold and flu medications. It also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. The company was founded in 1998 and is headquartered in Ji'An, China.
Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Universe Pharmaceuticals INC (UPC) is currently trading at $2.88 per share.
Its market cap is $1.87M and it is ranked 5488.
The stock is categorized in Healthcare, and its near-term technical picture sits at Neutral sentiment with RSI14 at 50, and moving averages showing SMA50 at $2.87 and SMA200 at $3.74.
Support sits at $2.54 and resistance at $3.38, with a 30-day range of $2.19 to $3.79. The stock exhibits an annualized volatility of 80%.
The long-range forecast points to upside over time, with the 2050 outlook showing an average price of $9.28 and a max of $20.51, corresponding to a ROI of 222.3 and a bullish longer-term stance.
A major floor 26.9% below — a decisive break under it would weaken the trend.
The nearest floor, 10.9% below — buyers have tended to step in here.
The nearest ceiling, 18.6% above — a clean break opens room to run.
A major ceiling 58.9% above — clearing it would confirm fresh momentum.
Key UPC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UPC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.75 | Buy | $2.75 | Buy |
| MA 10 | $2.70 | Buy | $2.75 | Buy |
| MA 20 | $2.84 | Buy | $2.81 | Buy |
| MA 50 | $2.88 | Sell | $2.93 | Sell |
| MA 100 | $3.21 | Sell | $3.60 | Sell |
| MA 200 | $3.73 | Sell | $28.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.20 | Neutral |
| Stoch RSI (14) | 96.32 | Sell |
| CCI (20) | 3.83 | Neutral |
| Williams %R (14) | -32.61 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 1.79 | Buy |
| Bollinger %B (20,2) | 0.51 | Neutral |
| Stochastic %K (14) | 67.39 | Neutral |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 51.73 | Neutral |
| Momentum (10) | 0.25 | Buy |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 2.79 | Buy |
| ADX (14) | 13.79 | Neutral |
| ATR (14) | 0.13 | Info |
The near-term technical picture is Neutral, with RSI14 at 50 signaling balanced momentum.
The price action sits around the 50-day moving average, with SMA50 at $2.87 and SMA200 at $3.74, while the current price is $2.88.
Key support and resistance are identified at $2.54 and $3.38, respectively. The thirty-day range spans from $2.19 to $3.79, and annualized volatility stands at 80%, indicating substantial swings within a narrow price band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.25 | $2.85 | $4.10 | 0% | Neutral | |
| $1.74 | $2.36 | $3.45 | -17% | Bearish | |
| $1.64 | $2.34 | $3.61 | -18% | Bearish | |
| $2.05 | $3.05 | $4.92 | +7% | Neutral | |
| $2.17 | $3.36 | $5.62 | +18% | Neutral | |
| $2.19 | $3.51 | $6.06 | +23% | Bullish | |
| $2.05 | $3.40 | $6.04 | +19% | Neutral | |
| $1.82 | $3.14 | $5.71 | +10% | Neutral | |
| $1.75 | $3.11 | $5.78 | +9% | Neutral | |
| $1.76 | $3.23 | $6.14 | +13% | Neutral | |
| $1.77 | $3.76 | $7.81 | +32% | Bullish | |
| $4.20 | $9.33 | $21.46 | +227% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.25 | $2.85 | $3.38 | +0.00% |
| June 2026 | $2.32 | $2.77 | $3.42 | -2.72% |
| July 2026 | $2.25 | $2.72 | $3.43 | -1.82% |
| August 2026 | $2.39 | $2.92 | $3.75 | +7.36% |
| September 2026 | $2.46 | $3.04 | $3.96 | +4.13% |
| October 2026 | $2.36 | $2.94 | $3.88 | -3.22% |
| November 2026 | $2.34 | $2.95 | $3.92 | +0.11% |
| December 2026 | $2.41 | $3.05 | $4.10 | +3.46% |
Click any year to see its month-by-month UPC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, UPC could reach as high as $4.10, with a base case around $2.85 and support toward $2.25 — roughly 0% from $2.85. A consolidation phase looks the most probable path here.
Expect UPC to range from $1.74 to $3.45 through 2027. The $2.36 average target implies a -17% move from current prices. That is -17% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The UPC price prediction for 2028 points to an average of $2.34 (low $1.64, high $3.61) — a potential decline of -18% on today's $2.85. Expect choppier, lower action through this leg of the cycle.
In 2029, UPC is projected to trade between $2.05 and $4.92, averaging $3.05 — a potential gain of +7% from today's $2.85. That is up +30% on the projected 2028 average. Price action looks broadly range-bound.
Universe Pharmaceuticals INC's 2030 outlook centres on $3.36, within a $2.17 to $5.62 range. That is up +10% on the projected 2029 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, UPC could reach as high as $6.06, with a base case around $3.51 and support toward $2.19 — roughly +23% from $2.85. Momentum favours further upside here.
Expect UPC to range from $2.05 to $6.04 through 2032. The $3.40 average target implies a +19% move from current prices. That is -3% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The UPC price prediction for 2033 points to an average of $3.14 (low $1.82, high $5.71) — a potential gain of +10% on today's $2.85. Price action looks broadly range-bound.
In 2034, UPC is projected to trade between $1.75 and $5.78, averaging $3.11 — a potential gain of +9% from today's $2.85. That is -1% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Universe Pharmaceuticals INC's 2035 outlook centres on $3.23, within a $1.76 to $6.14 range. That is up +4% on the projected 2034 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2040, UPC could reach as high as $7.81, with a base case around $3.76 and support toward $1.77 — roughly +32% from $2.85. Buyers look set to stay in control over this stretch.
Expect UPC to range from $4.20 to $21.46 through 2050. The $9.33 average target implies a +227% move from current prices. That is up +148% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in UPC today (≈ 350.877193 UPC) could be worth
$3,273.31
+$2,273.31 (+227%) by 2050 · US Dollar
Based on the average projected UPC price of $9.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UPCwould be worth at today's price.
$1,000 invested in UPC on May 27, 2025 (≈ 215.053759 UPC) would be worth
$612.9
-$387.1 (-38.7%) today · 0.61× · US Dollar
Based on a UPC entry price of $4.65 vs. today's $2.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.7 | $1,055.56 | +5.6% |
| 1 month ago | $3.05 | $934.43 | -6.6% |
| 3 months ago | $2.82 | $1,010.64 | +1.1% |
| 6 months ago | $3.94 | $723.35 | -27.7% |
| 1 year ago | $4.65 | $612.9 | -38.7% |
| All time (5.0y) ago | $11,520 | $0.25 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UPC forecast.
Our base-case forecast reaches $5.70 around 2050.
Implied market cap at $5.70: $3.6M
The multi-year forecast shows a path toward higher prices, with a neutral stance in 2026 giving way to more pronounced upside in later years.
For 2030, the avg price is forecast at $3.34 with a min of $2.24 and a max of $5.39, and a ROI of 16; sentiment is Neutral.
In 2031, the avg rises to $3.53 (min $2.30, max $5.87) with ROI 22.7 and a Bullish sentiment. In 2032, the avg is $3.46 (min $2.19, max $5.90) with ROI 20.1 and a Bullish sentiment.
The forecast continues through 2033–2035 with modest to mid-single-digit ROIs and neutral sentiment, then turns more bullish around 2040, where the avg is $3.98 (min $2.06, max $7.84) and ROI is 38.3. By 2050, the avg is $9.28 (min $4.18, max $20.51) with ROI 222.3 and a Bullish sentiment, reflecting meaningful long-run upside despite near-term volatility.
Tap a question to reveal the answer.
Avg $3.34, min $2.24, max $5.39, ROI 16, sentiment NEUTRAL.
The forecast shows several years with positive ROI (e.g., 2030: 16; 2031: 22.7; 2040: 38.3; 2050: 222.3) and Bullish sentiment in 2031, 2040, and 2050, but there are years with negative ROI (e.g., 2027: -15.9; 2028: -14.7). Returns are not guaranteed.
Yes, the 2050 max is $20.51, with an 2050 avg of $9.28 and a min of $4.18.
Current price is $2.88 and market cap is $1.87M.
RSI14 is 50 with Neutral sentiment; SMA50 is $2.87 and SMA200 is $3.74. Support is $2.54 and resistance is $3.38. The 30-day range is $2.19–$3.79, and annualized volatility is 80%.
Universe Pharmaceuticals INC Community Discussion
0Share your Universe Pharmaceuticals INC price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.